Elke De Schutter

Elke De Schutter

Auto-generated profile, based on publicly available information

Elke De Schutter

Clinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
ESElke De Schutter
Elke De Schutter
LCLieselot Croes
Lieselot Croes
JIJoe Ibrahim
Joe Ibrahim
PPPatrick Pauwels
Patrick Pauwels
KBKen Op de Beeck
Ken Op de Beeck
GCGuy Van Camp
Guy Van Camp

31 December 2021 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
ESElke De Schutter
Elke De Schutter
JRJana Ramon
Jana Ramon
BPBenjamin Pfeuty
Benjamin Pfeuty
Caroline De TenderCaroline De Tender
Caroline De Tender
SSStephan Stremersch
Stephan Stremersch
PVPeter Vandenabeele
Peter Vandenabeele
Secondary necrosis has long been perceived as an uncontrolled process resulting in total lysis of the apoptotic cell. Recently, it was shown that progression of apoptosis to secondary necrosis is regulated by Gasdermin E (GSDME), which requires activation by caspase-3. Although the contribution of GSDME in this context has been attributed to its pore-forming capacity, little is known about the kinetics and size characteristics of this. Here we report on the membrane permeabilizing features of GSDME by monitoring the influx and efflux of dextrans of different sizes into/from anti-Fas-treated L929sAhFas cells undergoing apoptosis-driven secondary necrosis. We found that GSDME accelerates cell lysis measured by SYTOX Blue staining but does not affect the exposure of phosphatidylserine on the plasma membrane. Furthermore, loss of GSDME expression clearly hampered the influx of fluorescently labeled dextrans while the efflux happened independently of the presence or absence of GSDME expression. Importantly, both in- and efflux of dextrans were dependent on their molecular weight. Altogether, our results demonstrate that GSDME regulates the passage of compounds together with other plasma membrane destabilizing subroutines.

2 September 2021 in iScience
Verified
Journal Article
Open access
FSFrançois Sipieter
François Sipieter
BCBenjamin Cappe
Benjamin Cappe
ALAymeric Leray
Aymeric Leray
ESElke De Schutter
Elke De Schutter
JBJolien Bridelance
Jolien Bridelance
FRFranck B. Riquet
Franck B. Riquet
ERK1/2 involvement in cell death remains unclear, although many studies have demonstrated the importance of ERK1/2 dynamics in determining cellular responses. To untangle how ERK1/2 contributes to two cell death programs, we investigated ERK1/2 signaling dynamics during hFasL-induced apoptosis and TNF-induced necroptosis in L929 cells. We observed that ERK1/2 inhibition sensitizes cells to apoptosis while delaying necroptosis. By monitoring ERK1/2 activity by live-cell imaging using an improved ERK1/2 biosensor (EKAR4.0), we reported differential ERK1/2 signaling dynamics between cell survival, apoptosis, and necroptosis. We also decrypted a temporally shifted amplitude- and frequency-modulated (AM/FM) ERK1/2 activity profile in necroptosis versus apoptosis. ERK1/2 inhibition, which disrupted ERK1/2 signaling dynamics, prevented TNF and IL-6 gene expression increase during TNF-induced necroptosis. Using an inducible cell line for activated MLKL, the final executioner of necroptosis, we showed ERK1/2 and its distinctive necroptotic ERK1/2 activity dynamics to be positioned downstream of MLKL.

19 July 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ESElke De Schutter
Elke De Schutter
BCBenjamin Cappe
Benjamin Cappe
BWBartosz Wiernicki
Bartosz Wiernicki
PVPeter Vandenabeele
Peter Vandenabeele
FRFranck B. Riquet
Franck B. Riquet

18 March 2024 in Prenatal Diagnosis
Verified
Journal Article
Closed access
NENathalie Vanden Eynde
Nathalie Vanden Eynde
EMEve Van Den Mooter
Eve Van Den Mooter
EVElise Vantroys
Elise Vantroys
ESElke De Schutter
Elke De Schutter
ALAstrid Leus
Astrid Leus
KBKim van Berkel
Kim van Berkel

5 August 2025 in EP Europace
Verified
Journal Article
Open access
CACharles Audiat
Charles Audiat
LPLuigi Pannone
Luigi Pannone
ASAntonio Sorgente
Antonio Sorgente
PVPasquale Vergara
Pasquale Vergara
DRDomenico Giovanni. Della Rocca
Domenico Giovanni. Della Rocca
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
Graphical Abstract Pathogenic/Likely Pathogenic variants identified in SCN5A and associated with ajmaline-induced ventricular fibrillation following ACMG guidelines